1.
|
Loehrer PJ and Einhorn LH: Drugs five
years later: cisplatin. Ann Int Med. 100:704–713. 1984.PubMed/NCBI
|
2.
|
Reedijk J: New clues for platinum
antitumor chemistry: kinetically controlled metal binding to DNA.
Proc Natl Acad Sci USA. 100:3611–3616. 2003. View Article : Google Scholar : PubMed/NCBI
|
3.
|
Woźniak K and Błasiak J: Recognition and
repair of DNA-cisplatin adducts. Acta Biochim Pol. 49:583–596.
2002.
|
4.
|
Basu A and Krishnamurthy S: Cellular
responses to cisplatin-induced DNA damage. J Nucleic Acids.
2010:2013672010. View Article : Google Scholar
|
5.
|
Mandic A, Hansson J, Linder S and Shoshan
MC: Cisplatin induces endoplasmic reticulum stress and
nucleus-independent apoptotic signaling. J Biol Chem.
278:9100–9106. 2003. View Article : Google Scholar : PubMed/NCBI
|
6.
|
Yu F, Megyesi J and Price PM: Cytoplasmic
initiation of cisplatin cytotoxicity. Am J Physiol Renal Physiol.
295:F44–F52. 2008. View Article : Google Scholar : PubMed/NCBI
|
7.
|
Martins I, Kepp O, Schlemmer F, Adjemian
S, Tailler M, Shen S, Michaud M, Menger L, Gdoura A, Tajeddine N,
Tesniere A, Zitvogel L and Kroemer G: Restoration of the
immunogenicity of cisplatin-induced cancer cell death by
endoplasmic reticulum stress. Oncogene. 30:1147–1158. 2011.
View Article : Google Scholar : PubMed/NCBI
|
8.
|
Gorman AM, Healy SJ, Jäger R and Samali A:
Stress management at the ER: regulators of ER stress-induced
apoptosis. Pharmacol Ther. 134:306–316. 2012. View Article : Google Scholar : PubMed/NCBI
|
9.
|
Verfaillie T, Salazar M, Velasco G and
Agostinis P: Linking ER stress to autophagy: potential implications
for cancer therapy. Int J Cell Biol. 2010:9305092010. View Article : Google Scholar : PubMed/NCBI
|
10.
|
Rodriguez D, Rojas-Rivera D and Hetz C:
Integrating stress signals at the endoplasmic reticulum: the BCL-2
protein family rheostat. Biochim Biophys Acta. 1813:564–574. 2011.
View Article : Google Scholar : PubMed/NCBI
|
11.
|
Heath-Engel HM, Chang NC and Shore GC: The
endoplasmic reticulum in apoptosis and autophagy: role of the BCL-2
protein family. Oncogene. 27:6419–6433. 2008. View Article : Google Scholar : PubMed/NCBI
|
12.
|
Boyce M and Yuan J: Cellular response to
endoplasmic reticulum stress: a matter of life or death. Cell Death
Differ. 13:363–373. 2006. View Article : Google Scholar : PubMed/NCBI
|
13.
|
Marciniak SJ and Ron D: Endoplasmic
reticulum stress signaling in disease. Physiol Rev. 86:1133–1149.
2006. View Article : Google Scholar : PubMed/NCBI
|
14.
|
Wu J and Kaufman RJ: From acute ER stress
to physiological roles of the unfolded protein response. Cell Death
Differ. 13:374–384. 2006. View Article : Google Scholar : PubMed/NCBI
|
15.
|
Lee AS: GRP78 induction in cancer:
therapeutic and prognostic implications. Cancer Res. 67:3496–3499.
2007. View Article : Google Scholar : PubMed/NCBI
|
16.
|
Pyrko P, Schönthal AH, Hofman FM, Chen TC
and Lee AS: The unfolded protein response regulator GRP78/BiP as a
novel target for increasing chemosensitivity in malignant gliomas.
Cancer Res. 67:9809–9816. 2007. View Article : Google Scholar : PubMed/NCBI
|
17.
|
Christofk HR, Vander Heiden MG, Harris MH,
Ramanathan A, Gerszten RE, Wei R, Fleming MD, Schreiber SL and
Cantley LC: The M2 splice isoform of pyruvate kinase is important
for cancer metabolism and tumour growth. Nature. 452:230–233. 2008.
View Article : Google Scholar : PubMed/NCBI
|
18.
|
Ranganathan AC, Zhang L, Adam AP and
Aguirre-Ghiso JA: Functional coupling of p38-induced up-regulation
of BiP and activation of RNA-dependent protein kinase-like
endoplasmic reticulum kinase to drug resistance of dormant
carcinoma cells. Cancer Res. 66:1702–1711. 2006. View Article : Google Scholar
|
19.
|
Li J and Lee AS: Stress induction of
GRP78/BiP and its role in cancer. Curr Mol Med. 6:45–54. 2006.
View Article : Google Scholar : PubMed/NCBI
|
20.
|
Wang L, Wang Q, Wang Z, Yu Z, Wang J,
Xiong H, Yin Q, Wang Y, Wang T and Tong S: Relationship between
chemosensitivity in vitro and the expression of GRP78 in non-small
cell lung cancer. Chin J Lung Canc. 9:483–487. 2006.(In
Chinese).
|
21.
|
Oyadomari S and Mori M: Roles of
CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ.
11:381–389. 2004. View Article : Google Scholar : PubMed/NCBI
|
22.
|
Yu F, Megyesi J, Safirstein RL and Price
PM: Involvement of the CDK2-E2F1 pathway in cisplatin cytotoxicity
in vitro and in vivo. Am J Physiol Renal Physiol. 293:F52–F59.
2007. View Article : Google Scholar : PubMed/NCBI
|
23.
|
Gaddameedhi S and Chatterjee S:
Association between the unfolded protein response, induced by
2-deoxyglucose, and hypersensitivity to cisplatin: a mechanistic
study employing molecular genomics. J Cancer Res Ther Suppl.
1:S61–S66. 2009.PubMed/NCBI
|
24.
|
Xu Y, Yu H, Qin H, Kang J, Yu C, Zhong J,
Su J, Li H and Sun L: Inhibition of autophagy enhances cisplatin
cytotoxicity through endoplasmic reticulum stress in human cervical
cancer cells. Cancer Lett. 314:232–243. 2012. View Article : Google Scholar
|
25.
|
Yu H, Su J, Xu Y, Kang J, Li H, Zhang L,
Yi H, Xiang X, Liu F and Sun L: p62/SQSTM1 involved in cisplatin
resistance in human ovarian cancer cells by clearing ubiquitinated
proteins. Eur J Cancer. 47:1585–1594. 2011. View Article : Google Scholar : PubMed/NCBI
|
26.
|
Peyrou M, Hanna PE and Cribb AE:
Cisplatin, gentamicin, and p-aminophenol induce markers of
endoplasmic reticulum stress in the rat kidneys. Toxicol Sci.
99:346–353. 2007. View Article : Google Scholar : PubMed/NCBI
|
27.
|
Peyrou M and Cribb AE: Effect of
endoplasmic reticulum stress preconditioning on cytotoxicity of
clinically relevant nephrotoxins in renal cell lines. Toxicol In
Vitro. 21:878–886. 2007. View Article : Google Scholar : PubMed/NCBI
|
28.
|
Wu CT, Sheu ML, Tsai KS, Chiang CK and Liu
SH: Salubrinal, an eIF2α dephosphorylation inhibitor, enhances
cisplatin-induced oxidative stress and nephrotoxicity in a mouse
model. Free Radic Biol Med. 51:671–680. 2011.
|
29.
|
Kong D, Zhuo L, Gao C, Shi S, Wang N,
Huang Z, Li W and Hao L: Erythropoietin protects against
cisplatin-induced nephrotoxicity by attenuating endoplasmic
reticulum stress-induced apoptosis. J Nephrol. 26:219–227. 2013.
View Article : Google Scholar
|
30.
|
Coling DE, Ding D, Young R, Lis M, Stofko
E, Blumenthal KM and Salvi RJ: Proteomic analysis of
cisplatin-induced cochlear damage: methods and early changes in
protein expression. Hear Res. 226:140–156. 2007. View Article : Google Scholar : PubMed/NCBI
|
31.
|
Ma H, Jones KR, Guo R, Xu P, Shen Y and
Ren J: Cisplatin compromises myocardial contractile function and
mitochondrial ultrastructure: role of endoplasmic reticulum stress.
Clin Exp Pharmacol Physiol. 37:460–465. 2010. View Article : Google Scholar
|
32.
|
Lin Y, Wang Z, Liu L and Chen L: Akt is
the downstream target of GRP78 in mediating cisplatin resistance in
ER stress-tolerant human lung cancer cells. Lung Cancer.
71:291–297. 2011. View Article : Google Scholar : PubMed/NCBI
|
33.
|
Wu ZZ and Chao CC: Knockdown of NAPA using
short-hairpin RNA sensitizes cancer cells to cisplatin:
implications to overcome chemoresistance. Biochem Pharmacol.
80:827–837. 2010. View Article : Google Scholar : PubMed/NCBI
|
34.
|
Feng R, Zhai WL, Yang HY, Jin H and Zhang
QX: Induction of ER stress protects gastric cancer cells against
apoptosis induced by cisplatin and doxorubicin through activation
of p38 MAPK. Biochem Biophys Res Commun. 406:299–304. 2011.
View Article : Google Scholar : PubMed/NCBI
|
35.
|
Chen R, Dai RY, Duan CY, Liu YP, Chen SK,
Yan DM, Chen CN, Wei M and Li H: Unfolded protein response
suppresses cisplatin-induced apoptosis via autophagy regulation in
human hepatocellular carcinoma cells. Folia Biol (Praha). 57:87–95.
2011.
|
36.
|
Rabik CA, Fishel ML, Holleran JL, Kasza K,
Kelley MR, Egorin MJ and Dolan ME: Enhancement of cisplatin
[cis-diammine dichloroplatinum (II)] cytotoxicity by
O6-benzylguanine involves endoplasmic reticulum stress. J Pharmacol
Exp Ther. 327:442–452. 2008.
|
37.
|
Nawrocki ST, Carew JS, Pino MS, Highshaw
RA, Dunner K Jr, Huang P, Abbruzzese JL and McConkey DJ: Bortezomib
sensitizes pancreatic cancer cells to endoplasmic reticulum
stress-mediated apoptosis. Cancer Res. 65:11658–11666. 2005.
View Article : Google Scholar : PubMed/NCBI
|
38.
|
Suzuki M, Endo M, Shinohara F, Echigo S
and Rikiishi H: Enhancement of cisplatin cytotoxicity by SAHA
involves endoplasmic reticulum stress-mediated apoptosis in oral
squamous cell carcinoma cells. Cancer Chemother Pharmacol.
64:1115–1122. 2009. View Article : Google Scholar : PubMed/NCBI
|
39.
|
Park IJ, Kim MJ, Park OJ, Choe W, Kang I,
Kim SS and Ha J: Cryptotanshinone induces ER stress-mediated
apoptosis in HepG2 and MCF7 cells. Apoptosis. 17:248–257. 2012.
View Article : Google Scholar : PubMed/NCBI
|
40.
|
Rovetta F, Stacchiotti A, Consiglio A,
Cadei M, Grigolato PG, Lavazza A, Rezzani R and Aleo MF: ER
signaling regulation drives the switch between autophagy and
apoptosis in NRK-52E cells exposed to cisplatin. Exp Cell Res.
318:238–250. 2012. View Article : Google Scholar
|